Brief: Clearside Biomedical Announces Fourth Quarter And Full Year 2022 Financial Results

Clearside Biomedical,

09/03/2023 21:08

March 9 (Reuters) - Clearside Biomedical Inc  CLSD.O :
    * CLEARSIDE BIOMEDICAL ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * NET LOSS FOR Q4 OF 2022 WAS $9.7 MILLION, OR $0.16 PER
SHARE OF
COMMON STOCK
    * Q4 EARNINGS PER SHARE VIEW $-0.13 -- REFINITIV IBES DATA
    * AS OF DECEMBER 31, 2022, CLEARSIDE'S CASH AND CASH
EQUIVALENTS
TOTALED $48.3 MILLION
    * WILL HAVE SUFFICIENT RESOURCES TO FUND ITS PLANNED
OPERATIONS
INTO Q2 OF 2024

Source text for Eikon:  ID:nGNXHr4yR 
Further company coverage:  CLSD.O 

 ((Reuters.Briefs@thomsonreuters.com;))